ALKS Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Disclosure Gap Stock Slips Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress FORA Q1 2026 Earnings Steep EPS Miss Overshadows Quarter as Revenue Remains Undisclosed MPAA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment XCF Global Inc SAFX Q1 2026 Earnings Narrow EPS Beat Sparks Cautious Optimism ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development CCM Q2 2016 Earnings Significant EPS Miss as Company Reports WiderThanExpected Loss ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus HTFC Q1 2026 Earnings Narrow EPS Miss Amid Stable Operations TME Q1 2026 Earnings EPS Beat Opaque as Stock Declines Amid Limited Disclosure Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported FBIN Q1 2026 Earnings Narrow EPS Miss on Flat Revenue as Stock Advances VITL Q1 2026 Earnings EPS Misses Estimates as Losses Weigh on PastureRaised Egg Producer GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues StepStone Group Inc Q1 2026 Earnings EPS Beats Estimates as Private Markets Momentum Continues Shares Dip Slightly CBNA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction MCRB Q1 2026 Earnings EPS Misses Estimates Stock Declines 417 Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Net Interest Margin Pressure Stock Edges Lower Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses